COVID-19 clinical update #38 with Dr. Daniel Griffin
November 28, 2020
(duration 34m)
[from description] ...l report on COVID-19, including new post-exposure guidelines from CDC, clinical trials of
Remdesivir and convalescent plasma, FDA EUA for baricitinib and Regeneron’s monoclonal antibody and ...
[from content:encoded] ...l report on COVID-19, including new post-exposure guidelines from CDC, clinical trials of
Remdesivir and convalescent plasma, FDA EUA for baricitinib and Regeneron’s monoclonal antibody and ...
[from itunes:keywords] viral,pandemic,virus,viruses,virology,covid19,sarscov2,
remdesivir,clinicalreport,baricitinib,monoclonalantibody,danielgriffin